American Century Companies Inc. Buys 28,784 Shares of AdaptHealth Corp. $AHCO

Key Points

• American Century Companies Inc. increased its stake in AdaptHealth Corp. by 13.7%, now owning 239,143 shares valued at approximately $2.6 million.
• Despite recent analyst downgrades, AdaptHealth maintains a consensus rating of "Buy" with an average price target of $13.40.
• The company's stock has seen a 2.7% increase recently, trading at $9.49 after reaching a 12-month high of $11.70.

American Century Companies Inc. lifted its stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 13.7% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 239,143 shares of the company's stock after buying an additional 28,784 shares during the quarter. American Century Companies Inc. owned approximately 0.18% of AdaptHealth worth $2,592,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC raised its stake in AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock valued at $81,000 after purchasing an additional 4,758 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in AdaptHealth during the first quarter valued at $114,000. Legato Capital Management LLC purchased a new stake in AdaptHealth during the first quarter valued at $167,000. Humankind Investments LLC raised its stake in AdaptHealth by 18.3% during the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after purchasing an additional 2,776 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in AdaptHealth by 25.3% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 15,871 shares of the company's stock valued at $172,000 after purchasing an additional 3,208 shares in the last quarter. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Trading Down 0.1%

AHCO stock traded down $0.01 during mid-day trading on Thursday, reaching $9.09. 276,985 shares of the stock traded hands, compared to its average volume of 1,401,439. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.70. The stock has a market capitalization of $1.23 billion, a PE ratio of 16.82, a PEG ratio of 1.06 and a beta of 1.59. The business has a 50-day moving average price of $9.33 and a two-hundred day moving average price of $9.25.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AHCO. Wall Street Zen raised shares of AdaptHealth from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Truist Financial decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research note on Monday, May 12th. Finally, Royal Bank Of Canada cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $13.40.

Insider Activity at AdaptHealth

In other news, Director David Solomon Williams III sold 8,200 shares of the company's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.73, for a total value of $79,786.00. Following the transaction, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. This represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.55% of the company's stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.